The announcement comes as Eli Lilly concludes a Phase 3 study that found orforglipron delivered "significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors" after 72 weeks
Generics require FDA approval by demonstrating bio-equivalence to the brand-name drug
If youre already experiencing a dry mouth, youre likely well into a fluid deficit
In many jurisdictions, a supplement must be registered and issued a certificate before it can be legally sold or distributed
Summary: Weight gain on Ozempic can occur due to medication interactions, underlying endocrine conditions, fluid retention, dietary compensation, subtherapeutic dosing, or metabolic adaptation despite semaglutide's typical weight-reducing effects